Profile
Sector:
Consumer DefensiveIndustry:
Household & Personal ProductsCountry:
United StatesIPO:
13 September 2019Website:
http://www.forhims.comNext earnings report:
26 February 2025Last dividends:
N/ANext dividends:
N/APrice
pre-market | 9 min agoDividend
Analysts recommendations
Institutional Ownership
HIMS Latest News
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS), the leading health and wellness platform, today announced Deb Autor, former deputy commissioner at the FDA, will join the company's board of directors, and Janet Stevens, a pharmaceutical quality expert, will join the company as Global Head of Quality & Safety. Hims & Hers continues to prioritize safety across its platform, offerings, and leadership so that every customer can have the confiden.
Hims & Hers has given back recent gains, but don't overlook the company's massive growth.
Should You Buy Hims & Hers Stock on the Dip?
Hims & Hers stands out from Teladoc by focusing on direct-to-consumer telehealth services, contrasting Teladoc's business-to-business model. This telehealth company provides personalized treatments to select conditions like weight loss, hair loss, and sexual health. A reverse DCF analysis suggests its current stock price is more than justified.
HIMS is enhancing its offerings and expanding the breadth of health and wellness products and services. However, macro challenges are likely to hurt its performance.
Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.
H&H's strong Q3 results signals a fundamental shift in the healthcare industry. GLP-1 drugs are certainly a growth catalyst for H&H but it is just a tiny component of the overall investment thesis. H&H investments in AI will drive massive efficiency gains while delivering immense value for providers and patients.
Hims & Hers is a rapidly emerging player in telehealth and wellness, catering to millennials and Gen Z. The company reported a 77% year-over-year revenue growth, with a subscriber base of 2 million. Hims & Hers' strategic marketing investments have led to positive net income, with potential for further growth and profitability.
Hims & Hers Health (HIMS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Hims & Hers strong performance involves much more than just GLP-1 drugs.
What type of business is Hims & Hers Health?
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.
What sector is Hims & Hers Health in?
Hims & Hers Health is in the Consumer Defensive sector
What industry is Hims & Hers Health in?
Hims & Hers Health is in the Household & Personal Products industry
What country is Hims & Hers Health from?
Hims & Hers Health is headquartered in United States
When did Hims & Hers Health go public?
Hims & Hers Health initial public offering (IPO) was on 13 September 2019
What is Hims & Hers Health website?
https://www.forhims.com
Is Hims & Hers Health in the S&P 500?
No, Hims & Hers Health is not included in the S&P 500 index
Is Hims & Hers Health in the NASDAQ 100?
No, Hims & Hers Health is not included in the NASDAQ 100 index
Is Hims & Hers Health in the Dow Jones?
No, Hims & Hers Health is not included in the Dow Jones index
When was Hims & Hers Health the previous earnings report?
No data
When does Hims & Hers Health earnings report?
The next expected earnings date for Hims & Hers Health is 26 February 2025